NanoSilikhan Advanced Materials Shares Results in Preventing Drug Counterfeiting at Korea-Middle East Cooperation Forum
- Input
- 2026-11-20 12:36:08
- Updated
- 2026-11-20 12:36:08

[Financial News] NanoSilikhan Advanced Materials said on the 20th that it shared results from its efforts to prevent pharmaceutical counterfeiting in the Middle East and reforms in the health sector at the 22nd Korea-Middle East Cooperation Forum, held on the 17th at LOTTE HOTELS & RESORTS in Sogong-dong, Seoul.
The forum, co-hosted by the Korea-Arab Society (KAS) and the Jeju Peace Institute, was held under the theme “Innovative Partnership Between Korea and the Middle East in an Era of Great Transformation.” Participants discussed the situation in the Middle East, economic cooperation between Korea and the Middle East, and new sources of growth. The forum also provided an opportunity for businesspeople from both sides to interact. KAS is a public-private joint organization established in 2008 to promote exchanges between Korea and 22 Arab countries.
Amer Barzani, CEO of multinational investment firm GEG Group, spoke at the forum and presented results from local projects pursued after the company formed a partnership with NanoSilikhan Advanced Materials in 2019. “Advanced nanomagnetic-based technology and security solutions played a key role in improving the institutional framework in the local health sector and eliminating the distribution of illegal and counterfeit medicines,” Barzani said. “We were able to provide tangible support for improving the local medical environment and reforming the health sector.”
Barzani said that, as a result of the full-scale deployment of the technology starting in 2022, the local government had saved more than $200 million (267 billion won) in public funds. “The savings ultimately translated directly into easing the financial burden on ordinary citizens and consumers who buy medicines,” he said. “By carrying out projects through our long-term partnership with NanoSilikhan Advanced Materials, which has continued since 2019, we were able to achieve tangible results.”
Choi Jong-uk, CEO of NanoSilikhan Advanced Materials, who spoke that afternoon, outlined plans to expand the business based on the company’s proven technology and cooperation results in the Middle East. “Building on the Middle East market, which has entered a stable phase, we will broaden our reach into Africa and continue to pursue revenue growth with our distinctive security technology,” Choi said.
NanoSilikhan Advanced Materials previously disclosed that on the 19th it had signed a contract worth $1.05 million (1.4 billion won) to supply anti-counterfeiting security products to a company that provides pharmaceutical security solutions to governments in the Middle East.
A representative of NanoSilikhan Advanced Materials said, “The Korea-Middle East Cooperation Forum provided an opportunity to share the results of our cooperation, which has contributed to pharmaceutical safety and health sector reform in the Middle East,” adding, “We will create sustained growth drivers by combining stable operations in the Middle East market, expansion into Africa, and the competitiveness of our distinctive security technology.”
[email protected] Choi Doo-seon Reporter